Overview of Atopic Dermatitis in Different Ethnic Groups

Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a high prevalence worldwide, including countries from Asia, Africa, and Latin America, and in different ethnic groups. In recent years, more attention has been placed on the heterogeneity of AD associated with multiple factors...

Full description

Bibliographic Details
Main Authors: Andrea Chiricozzi, Martina Maurelli, Laura Calabrese, Ketty Peris, Giampiero Girolomoni
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/7/2701
_version_ 1797607572678639616
author Andrea Chiricozzi
Martina Maurelli
Laura Calabrese
Ketty Peris
Giampiero Girolomoni
author_facet Andrea Chiricozzi
Martina Maurelli
Laura Calabrese
Ketty Peris
Giampiero Girolomoni
author_sort Andrea Chiricozzi
collection DOAJ
description Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a high prevalence worldwide, including countries from Asia, Africa, and Latin America, and in different ethnic groups. In recent years, more attention has been placed on the heterogeneity of AD associated with multiple factors, including a patient’s ethnic background, resulting in an increasing body of clinical, genetic, epidemiologic, and immune-phenotypic evidence that delineates differences in AD among racial groups. Filaggrin (FLG) mutations, the strongest genetic risk factor for the development of AD, are detected in up to 50% of European and 27% of Asian AD patients, but very rarely in Africans. Th2 hyperactivation is a common attribute of all ethnic groups, though the Asian endotype of AD is also characterized by an increased Th17-mediated signal, whereas African Americans show a strong Th2/Th22 signature and an absence of Th1/Th17 skewing. In addition, the ethnic heterogeneity of AD may hold important therapeutic implications as a patient’s genetic predisposition may affect treatment response and, thereby, a tailored strategy that better targets the dominant immunologic pathways in each ethnic subgroup may be envisaged. Nevertheless, white patients with AD represent the largest ethnicity enrolled and tested in clinical trials and the most treated in a real-world setting, limiting investigations about safety and efficacy across different ethnicities. The purpose of this review is to describe the heterogeneity in the pathophysiology of AD across ethnicities and its potential therapeutic implications.
first_indexed 2024-03-11T05:32:51Z
format Article
id doaj.art-6ff2b70293f64b71a99df4fc99a95a03
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T05:32:51Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-6ff2b70293f64b71a99df4fc99a95a032023-11-17T17:00:44ZengMDPI AGJournal of Clinical Medicine2077-03832023-04-01127270110.3390/jcm12072701Overview of Atopic Dermatitis in Different Ethnic GroupsAndrea Chiricozzi0Martina Maurelli1Laura Calabrese2Ketty Peris3Giampiero Girolomoni4UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, 00168 Rome, ItalySection of Dermatology and Venereology, Department of Medicine, University of Verona, 37126 Verona, ItalyUOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, 00168 Rome, ItalyUOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, 00168 Rome, ItalySection of Dermatology and Venereology, Department of Medicine, University of Verona, 37126 Verona, ItalyAtopic dermatitis (AD) is a common chronic inflammatory skin disease with a high prevalence worldwide, including countries from Asia, Africa, and Latin America, and in different ethnic groups. In recent years, more attention has been placed on the heterogeneity of AD associated with multiple factors, including a patient’s ethnic background, resulting in an increasing body of clinical, genetic, epidemiologic, and immune-phenotypic evidence that delineates differences in AD among racial groups. Filaggrin (FLG) mutations, the strongest genetic risk factor for the development of AD, are detected in up to 50% of European and 27% of Asian AD patients, but very rarely in Africans. Th2 hyperactivation is a common attribute of all ethnic groups, though the Asian endotype of AD is also characterized by an increased Th17-mediated signal, whereas African Americans show a strong Th2/Th22 signature and an absence of Th1/Th17 skewing. In addition, the ethnic heterogeneity of AD may hold important therapeutic implications as a patient’s genetic predisposition may affect treatment response and, thereby, a tailored strategy that better targets the dominant immunologic pathways in each ethnic subgroup may be envisaged. Nevertheless, white patients with AD represent the largest ethnicity enrolled and tested in clinical trials and the most treated in a real-world setting, limiting investigations about safety and efficacy across different ethnicities. The purpose of this review is to describe the heterogeneity in the pathophysiology of AD across ethnicities and its potential therapeutic implications.https://www.mdpi.com/2077-0383/12/7/2701atopic eczemadermatitisallergyitchskin diseasetreatment
spellingShingle Andrea Chiricozzi
Martina Maurelli
Laura Calabrese
Ketty Peris
Giampiero Girolomoni
Overview of Atopic Dermatitis in Different Ethnic Groups
Journal of Clinical Medicine
atopic eczema
dermatitis
allergy
itch
skin disease
treatment
title Overview of Atopic Dermatitis in Different Ethnic Groups
title_full Overview of Atopic Dermatitis in Different Ethnic Groups
title_fullStr Overview of Atopic Dermatitis in Different Ethnic Groups
title_full_unstemmed Overview of Atopic Dermatitis in Different Ethnic Groups
title_short Overview of Atopic Dermatitis in Different Ethnic Groups
title_sort overview of atopic dermatitis in different ethnic groups
topic atopic eczema
dermatitis
allergy
itch
skin disease
treatment
url https://www.mdpi.com/2077-0383/12/7/2701
work_keys_str_mv AT andreachiricozzi overviewofatopicdermatitisindifferentethnicgroups
AT martinamaurelli overviewofatopicdermatitisindifferentethnicgroups
AT lauracalabrese overviewofatopicdermatitisindifferentethnicgroups
AT kettyperis overviewofatopicdermatitisindifferentethnicgroups
AT giampierogirolomoni overviewofatopicdermatitisindifferentethnicgroups